Literature DB >> 31723461

Relationship Between Level of Serum 25-Hydroxyvitamin D and Risk of Squamous Cell Carcinoma in an Iranian Population.

Mahboobeh-Sadat Hosseini1, Fereshteh Salarvand2, Amir Houshang Ehsani2, Pedram Noormohammadpour2, Shadi Azizzadeh2, Mohaddese Mousavi3, Mona Morsali3.   

Abstract

BACKGROUND: The relationship between vitamin D and skin squamous cell carcinoma (SCC) is not well defined.
OBJECTIVE: To investigate the relationship between vitamin D levels and the incidence of skin SCC for the first time in Iran. METHODS AND STUDY
DESIGN: In this case-control study, 126 subjects were enrolled (63 in each group) out of referents to Razi Skin Hospital in Tehran in 2014. The risk factors for cancer gathered by self-reported questionnaires and blood samples were obtained to measure the level of 25-hydroxyvitamin D. Multivariate logistic regression was used to neutralize the effect of confounding factors.
RESULTS: Cases of SCC were more likely to be in men, older than 49 years and working in an outdoor environment, and with longtime exposure to sunlight and a personal history of skin cancers. Family history of skin cancer and of cigarette smoking were not significantly related to SCC. In the SCC and control groups, 69.8% and 31.7%, respectively, had sufficient levels of vitamin D (P < 0.001). Mean level of 25-hydroxyvitamin D was 40.99 ng/mL in the SCC group and 26.34 ng/mL in the control group (P < 0.05). In the unadjusted model, the level of vitamin D as a continuous variable was positively related to SCC risk. In the adjusted model, vitamin D did not independently predict the likelihood of SCC.
CONCLUSION: Vitamin D level and SCC risk are directly related, although not in an independent fashion. Indeed, this relation is severely confounded by exposure to sunlight, which was evidenced by an increased vitamin D level in the people working outside and the higher prevalence of SCC in the same population. Copyright: ©2019 Hosseini et al.

Entities:  

Keywords:  cancer epidemiology; skin cancer; squamous cell carcinoma; supplements; vitamin D

Year:  2019        PMID: 31723461      PMCID: PMC6830561          DOI: 10.5826/dpc.0904a06

Source DB:  PubMed          Journal:  Dermatol Pract Concept        ISSN: 2160-9381


  20 in total

1.  High plasma 25-hydroxyvitamin D and high risk of nonmelanoma skin cancer: a Mendelian randomization study of 97 849 individuals.

Authors:  U C Winsløw; B G Nordestgaard; S Afzal
Journal:  Br J Dermatol       Date:  2018-04-14       Impact factor: 9.302

2.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Authors:  Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

Review 3.  Endocrine actions of vitamin D in skin: Relevance for photocarcinogenesis of non-melanoma skin cancer, and beyond.

Authors:  Jörg Reichrath; Roman Saternus; Thomas Vogt
Journal:  Mol Cell Endocrinol       Date:  2017-05-16       Impact factor: 4.102

4.  Vitamin D and nonmelanoma skin cancer in a health maintenance organization cohort.

Authors:  Melody J Eide; Dayna A Johnson; Gordon R Jacobsen; Richard J Krajenta; D Sudhaker Rao; Henry W Lim; Christine C Johnson
Journal:  Arch Dermatol       Date:  2011-08-15

Review 5.  The role of vitamin D in cancer prevention: does UV protection conflict with the need to raise low levels of vitamin D?

Authors:  Hajo Zeeb; Rüdiger Greinert
Journal:  Dtsch Arztebl Int       Date:  2010-09-17       Impact factor: 5.594

Review 6.  Vitamin D and skin cancer.

Authors:  Daniel D Bikle
Journal:  J Nutr       Date:  2004-12       Impact factor: 4.798

7.  Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma.

Authors:  Maryam M Asgari; Jean Tang; Margaret E Warton; Mary-Margaret Chren; Charles P Quesenberry; Dan Bikle; Ronald L Horst; Norman Orentreich; Joseph H Vogelman; Gary D Friedman
Journal:  J Invest Dermatol       Date:  2009-12-31       Impact factor: 8.551

8.  Pre-diagnostic plasma 25-hydroxyvitamin D levels and risk of non-melanoma skin cancer in women.

Authors:  Geyu Liang; Hongmei Nan; Abrar A Qureshi; Jiali Han
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

9.  Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men.

Authors:  Jean Y Tang; Neeta Parimi; Angela Wu; W John Boscardin; James M Shikany; Mary-Margaret Chren; Steven R Cummings; Ervin H Epstein; Douglas C Bauer
Journal:  Cancer Causes Control       Date:  2010-03       Impact factor: 2.506

10.  Prevalence of vitamin D deficiency in Iran: A systematic review and meta-analysis.

Authors:  Salam Vatandost; Marzieh Jahani; Ali Afshari; Mohammad Reza Amiri; Rashid Heidarimoghadam; Younes Mohammadi
Journal:  Nutr Health       Date:  2018-10-08
View more
  2 in total

1.  Serum 25-Hydroxyvitamin D and Subsequent Cancer Incidence and Mortality: A Population-Based Retrospective Cohort Study.

Authors:  Casey R Johnson; Daniel V Dudenkov; Kristin C Mara; Philip R Fischer; Julie A Maxson; Tom D Thacher
Journal:  Mayo Clin Proc       Date:  2021-08       Impact factor: 11.104

Review 2.  Exposome and Skin. Part 2. The Influential Role of the Exposome, Beyond UVR, in Actinic Keratosis, Bowen's Disease and Squamous Cell Carcinoma: A Proposal.

Authors:  Manuel Molina-García; Josep Malvehy; Corinne Granger; Aurora Garre; Carles Trullàs; Susana Puig
Journal:  Dermatol Ther (Heidelb)       Date:  2022-02-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.